Radioimmunotherapy in Oncology: Overview of the Last Decade Clinical Trials
The specific irradiation of tumors with selective radiolabeled antibodies constitutes an attractive therapeutic approach. Consequent preclinical research has been conducted by both biologists to identify pertinent targets and to select corresponding antibodies (mAb) and by radiochemists to radiolabe...
Guardado en:
Autores principales: | Aurélie Rondon, Jacques Rouanet, Françoise Degoul |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/84b9eabcb1ee4a7680734cf6d002e4ee |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The natural sulfoglycolipid derivative SQAP improves the therapeutic efficacy of tissue factor-targeted radioimmunotherapy in the stroma-rich pancreatic cancer model BxPC-3
por: Yoichi Takakusagi, et al.
Publicado: (2022) -
Immunotherapy and Radioimmunotherapy for Desmoplastic Small Round Cell Tumor
por: Madelyn Espinosa-Cotton, et al.
Publicado: (2021) - Oncolog-Hematolog
- Romanian Journal of Oncology & Hematology
-
Scope of Artificial Intelligence in Gastrointestinal Oncology
por: Hemant Goyal, et al.
Publicado: (2021)